Bladder cancer trial engagement study

This study follows people with bladder cancer (except the very earliest Ta stage) to better understand the disease and improve care. You may be asked for basic health information and consent, and joining does not prevent you from joining other studies.

This study collects samples from people who may have bladder cancer or already have a bladder cancer diagnosis. Those samples will help researchers develop better biomarkers (lab tests) and new therapies in the future.

This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.

This study looks at how bladder cancer is treated and what biological markers are present in patients in Russia. If you join, you may help doctors learn more about which treatments work best based on your tumor type.

This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.

This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.